The new findings of the Msi2/Numb/Notch signaling pathway may be a key to understanding a new insight to hematopoietic malignancies, especially in the advanced stages of CML blastic crisis (38, 95) (Figure.2 B). This evidence concerns the gene MSI2 and chronic myelogenous leukemia, BCR-ABL1 positive.